ロード中...
Cost-effectiveness analysis of IDegLira versus basal-bolus insulin for patients with type 2 diabetes in the Slovak health system
AIMS: To investigate the cost-effectiveness of once-daily insulin degludec/liraglutide (IDegLira) versus basal-bolus therapy in patients with type 2 diabetes not meeting glycemic targets on basal insulin from a healthcare payer perspective in Slovakia. METHODS: Long-term clinical and economic outcom...
保存先:
| 出版年: | Clinicoecon Outcomes Res |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5731336/ https://ncbi.nlm.nih.gov/pubmed/29276398 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S143127 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|